Overview
Randomized controlled trial with a wait list control arm. Participants will be randomized 1:1 to T1CARE or wait list usual care arm. Participants will be recruited from the Yale Adult and Pediatric Diabetes Centers. Patients assigned to T1CARE will receive support from a Community Health Navigator at Project Access-New Haven.
Description
Primary Objective To determine whether the T1CARE intervention improves resolution of health-related social needs compared to usual care.
Secondary Objectives
- To assess the feasibility and acceptability of the T1CARE intervention.
- To evaluate the impact of T1CARE on patient-reported outcomes, including diabetes distress, illness intrusiveness, and quality of life.
- To examine preliminary effects on clinical outcomes, particularly changes in HbA1c.
Eligibility
Inclusion Criteria:
- Type 1 Diabetes
- fluent in Spanish or English who reside in the greater New Haven area
Exclusion Criteria:
- cognitive impairment and otherwise unable to give written informed consent about participating in this study